Cressman, S., Karsan, A., Hogge, D., McPherson, E., Bolbocean, C., Regier, D., & Peacock, S. (2016). Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia. Wiley.
Chicago Style (17th ed.) CitationCressman, S., A. Karsan, DE Hogge, E. McPherson, C. Bolbocean, DA Regier, and SJ Peacock. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.
ציטוט MLACressman, S., et al. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.